×
ADVERTISEMENT

mirvetuximab soravtansine

Elahere Fully Approved for Certain Ovarian, Fallopian Tube or Primary Peritoneal Cancer

The FDA approved Elahere for adult patients with FRalpha-positive, platinum-resistant epithelial ovarian, fallopian ...

MARCH 25, 2024

Load more